Severe acute respiratory syndrome coronavirus 2 causes direct damage to the airway
epithelium, enabling aspergillus invasion. Reports of COVID-19-associated pulmonary …

Introduction The recovery of other pathogens in patients with SARS-CoV-2 infection has
been reported, either at the time of a SARS-CoV-2 infection diagnosis (co-infection) or …

Abstract Coronavirus disease 2019 (COVID-19) infections may be associated with a wide
range of bacterial and fungal co-infections. We report the case of a patient with COVID-19 …

Abstract Objectives Coronavirus disease 2019 (COVID-19)-associated pulmonary
aspergillosis (CAPA) has emerged as a complication in critically ill COVID-19 patients. The …

Pneumonia caused by severe acute respiratory syndrome coronavirus 2 emerged in China
at the end of 2019. Because of the severe immunomodulation and lymphocyte depletion …

Aspergillosis complicating severe influenza infection has been increasingly detected
worldwide. Recently, coronavirus disease–associated pulmonary aspergillosis (CAPA) has …

Background The incidence of secondary pulmonary infections is not well described in
hospitalized COVID-19 patients. Understanding the incidence of secondary pulmonary …

Individuals suffering from severe viral respiratory tract infections have recently emerged as
“at risk” groups for developing invasive fungal infections. Influenza virus is one of the most …

Rationale: Whether severe coronavirus disease (COVID-19) is a significant risk factor for the
development of invasive fungal superinfections is of great medical interest and remains, for …

Purpose Invasive pulmonary aspergillosis (IPA) is increasingly reported in patients with
severe coronavirus disease 2019 (COVID-19) admitted to the intensive care unit (ICU) …